Loading asset research
Q2 2026 earnings · Sep 28
Psyence Biomedical Ltd. Common Shares
PBMNasdaq · USD · StocksQuote as of · Exchange session not verified$5.40
+8.65%
Today
PBM
Loading 1D prices…
Market cap
$16.9M
Volume
130.7K
52w high
$216.4152w low
$1.92Company profile
Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Toronto, ON, United States
Employees
12
Fiscal year end
0331
CIK
1985062
Session & valuation
Open$5.02
Previous close$4.97
Day high$5.63
Day low$4.93
30-day avg. volume80.6K
Outstanding shares2.3M
Diluted EPS$32.76
Latest annual period
P/E (trailing)0.16
P/E (forward)—
Price / book0.73
Beta1.73
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ENLVEnlivex Ltd. Ordinary Shares | $16.8M | $0.00 | — | $25.48 | -3.16% | Buy |
| PDSBPDS Biotechnology Corporation Common Stock | $16.5M | $0.00 | — | -$0.74 | -6.44% | Buy |
| BIVIBioVie Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.05 | +1.05% | Unrated |
| AEONAEON Biopharma Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.95 | +12.76% | Buy |
| KTTAPasithea Therapeutics Corp. Common Stock | $17.7M | $0.00 | — | -$2.91 | -1.85% | Buy |